MedPath

Self-Management of Chronic Low Back Pain: Targeting Patient Activation

Not Applicable
Completed
Conditions
Patient Activation
Chronic Low-back Pain
Registration Number
NCT06236529
Lead Sponsor
Johns Hopkins University
Brief Summary

Patients with chronic low back (cLBP) pain report reduced physical function and ability to participate in social roles and are more likely to use opioid pain medications. While self-management interventions have been shown to support these patients, effectiveness has been limited due to poor patient engagement. "Patient activation" encompasses the skills, knowledge, and motivation that a person has to manage the person's health. Supporting patient activation may improve the effectiveness of self-management for cLBP.

In this single-masked pilot study of adults with cLBP, patients were randomized to receive either no intervention (control) or 6 weekly sessions of an evidence-based web-based self-management program (SMP) with or without health behavior change counseling (HBCC) using motivational interviewing. Participants were assessed at baseline and at 12 and 26 weeks using the Patient Activation Measure, Oswestry Disability Index and Patient-Reported Outcomes Measurement Information System (PROMIS) physical function, social role participation, and pain interference. The investigators assessed acceptability and feasibility based on recruitment, session attendance, and follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Adults (18+ years of age)
  • Seen in primary or specialty care practice for non-specific low back pain
  • Chronic low back pain per the NIH Task Force on Research Standards for cLBP
  • Worst back pain of at least 4/10 points
  • Oswestry disability index of at least 24%
  • English speaking
Exclusion Criteria
  • History of lumbar spine decompression/laminectomy or fusion surgery in the past 6 months
  • Possible non-musculoskeletal cause for LBP symptoms diagnosis at baseline
  • "Red flag" LBP diagnosis in the previous 6 months (e.g., cauda equina syndrome, osteomyelitis, or spinal neoplasm)
  • Neurological disorder resulting in moderate to severe movement dysfunction
  • Presence of any psychotic disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Acceptability of researchBaseline

Acceptability - at least 50% of individuals approached agree to eligibility screening for the study, having at least 30% of those who were deemed eligible for the study agree to participate

Feasibility of studyBaseline

Feasibility - (1) having at least 80% of enrolled participants attend at least 3 of the 6 scheduled self-management program sessions; and (2) having a loss to follow-up rate of \< 20% of enrolled participants over the 26-week study

Secondary Outcome Measures
NameTimeMethod
Oswestry Disability Index (ODI) score12 weeks

Pain-related disability was assessed using the ODI, a 10-item measure of low back pain-related disability that evaluates the current effect of a patient's low back pain on various aspects of daily living. ODI scores range from 0 to 100, with higher scores indicating greater disability.

Patient Activation Measure (PAM) score12 weeks

The Patient Activation Measure (PAM) is a 13-item instrument where patients are provided 5 response options, ranging from "strongly agree" to "strongly disagree." Based on their answers, patients were assigned a numerical score ranging from 0 (no activation) to 100 (highest activation), and the score was used to stratify patients into 1 of 4 stages of activation: stage 1 (believes taking an active role is important), stage 2 (has the confidence and knowledge to take action), stage 3 (takes action), and stage 4 (stays the course under stress)

Trial Locations

Locations (1)

Johns Hopkins University School of Medicine

🇺🇸

Baltimore, Maryland, United States

Johns Hopkins University School of Medicine
🇺🇸Baltimore, Maryland, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.